Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome-Reference-Cited by-同舟云学术

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome

Published:2024-08-15 Issue:1 Volume:23 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Tan Cuiyu,Huang Shuqiang,Xu Liying,Zhang Tongtong,Yuan Xiaojun,Li Zhihong,Chen Miaoqi,Chen Cairong,Yan Qiuxia

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12944-024-02237-3.pdf

Reference62 articles.

1. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487–525. https://doi.org/10.1210/er.2015-1018.

2. Alesi S, Ee C, Moran LJ. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. 2022;13(4):1243–66. https://doi.org/10.1093/advances/nmab141.

3. Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–80. https://doi.org/10.1016/s2213-8587(22)00163-2.

4. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta. 2017;1863(5):1037–45. https://doi.org/10.1016/j.bbadis.2016.04.017.

5. Mancini A, Bruno C, Vergani E, d'Abate C, Giacchi E, Silvestrini A. Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights. 2021;22(4). https://doi.org/10.3390/ijms22041667.